Publication: Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: An analysis of 53 cases
dc.contributor.author | Onal, Ugur | |
dc.contributor.author | Akyol, Deniz | |
dc.contributor.author | Kaya, Arda | |
dc.contributor.author | Baskol, Dilsah | |
dc.contributor.author | Kenanoglu, Buse | |
dc.contributor.author | Sanlidag, Gamze | |
dc.contributor.author | Onal, Ayse Uyan | |
dc.contributor.author | Avsar, Cansu Bulut | |
dc.contributor.author | Mert, Merve | |
dc.contributor.author | Memetali, Seichan | |
dc.contributor.author | Erdem, Hueseyin Aytac | |
dc.contributor.author | Bozkurt, Devrim | |
dc.contributor.author | Simsir, Adnan | |
dc.contributor.author | Bozbiyik, Osman | |
dc.contributor.author | Kahraman, Umit | |
dc.contributor.author | Ozgiray, Erkin | |
dc.contributor.author | Korkmaz, Pervin | |
dc.contributor.author | Cilli, Feriha | |
dc.contributor.author | Pullukcu, Husnu | |
dc.contributor.author | Yamazhan, Tansu | |
dc.contributor.author | Tasbakan, Meltem Isikgoz | |
dc.contributor.author | Arda, Bilgin | |
dc.contributor.author | Ulusoy, Sercan | |
dc.contributor.author | Sipahi, Oguz Resat | |
dc.contributor.buuauthor | ÖNAL, UĞUR | |
dc.contributor.orcid | 0000-0001-6194-3254 | |
dc.contributor.researcherid | JCO-3678-2023 | |
dc.date.accessioned | 2024-11-07T07:58:26Z | |
dc.date.available | 2024-11-07T07:58:26Z | |
dc.date.issued | 2023-10-01 | |
dc.description.abstract | Herein, we aimed to describe the outcomes of patients with blood stream infections due to carbapenem-resistant Klebsiella pneumoniae (CR-Kp) who received ertapenem plus meropenem combination treatment (EMCT). A total of 53 patients with culture proven CR-Kp bacteremia treated with ertapenem + meropenem were included. The patients with secondary bacteremia due to urinary tract infection exhibited a significantly lower 1-month mortality (OMM), particularly in those with microbiological eradication and those with end-of-treatment success. Salvage EMCT resulted in 49% 1-month survival. | |
dc.identifier.doi | 10.1007/s10096-023-04660-3 | |
dc.identifier.endpage | 1273 | |
dc.identifier.issn | 0934-9723 | |
dc.identifier.issue | 10 | |
dc.identifier.startpage | 1269 | |
dc.identifier.uri | https://doi.org/10.1007/s10096-023-04660-3 | |
dc.identifier.uri | https://hdl.handle.net/11452/47542 | |
dc.identifier.volume | 42 | |
dc.identifier.wos | 001063955100001 | |
dc.indexed.wos | WOS.SCI | |
dc.language.iso | en | |
dc.publisher | Springer | |
dc.relation.journal | European Journal Of Clinical Microbiology & Infectious Diseases | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Therapy | |
dc.subject | Infections | |
dc.subject | Double carbapenem therapy | |
dc.subject | Carbapenem-resistant klebsiella pneumonia | |
dc.subject | Bacteremia | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Infectious diseases | |
dc.subject | Microbiology | |
dc.subject | Infectious diseases | |
dc.subject | Microbiology | |
dc.title | Ertapenem plus meropenem combination treatment in carbapenem-resistant Klebsiella pneumoniae bacteremia: An analysis of 53 cases | |
dc.type | Article | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 73351d49-e518-4e6a-8f69-c922f8f24611 | |
relation.isAuthorOfPublication.latestForDiscovery | 73351d49-e518-4e6a-8f69-c922f8f24611 |